Peripheral T cell Lymphoma, NOS Flashcards

1
Q

What is the definition of

peripheral T cell lymphoma, NOS ?

A
  • heterogeneous category of nodal and extranodal mature T cell lymphomas
  • do not fit into any specific entity
  • typically presents in adults and has an aggressive clinical course
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the epidemiology and etiology

for PTCL, NOS?

A
  • account for ~30% of PTCLs in western countries
  • very rare in children, usually adults
  • male:female ratio is 2:1
  • EBV infection is reported in a small number of cases
    • usually EBV is found in the background cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the localization of

PTCL, NOS ?

A
  • most patients have peripheral lymph node involvement, but any site can be affected
  • advanced stage disease is common
    • bone marrow, liver, spleen, extranodal tissue
      • usually sin and GI tract
      • other less frequently involved sites include CNS and lung
    • peripheral blood sometimes involved but leukemic presentation is uncommon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features ?

A
  • often patients present with enlarged lymph nodes
  • most have advanced stage disease with B symptoms
  • rarely paraneoplastic syndromes can be seen:
    • eosinophilia
    • pruritis
    • hemophagocytic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the microscopic findings

of PTCL, NOS ?

A
  • paracortical or diffuse infiltrates with effacement of normal lymph node architecture
  • broad cytological spectrum
    • most cases: medium to large lymphocytes with irregular, pleomorphic , hyperchromatic or vesicular nuclei
    • prominent nucleoli and many mitotic figures
    • clear cells with RS cell morphology can be seen
    • rare cases with predominantly small lymphoid cells can be seen
  • Note:
    • features of AITL should not be seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the inflammatory background

like in PTCL, NOS?

A
  • mixed inflammatory background is often present
    • small lymphocytes, plasma cells, eosinophils
    • large B cells (may be clonal irrespective of EBV infection)
    • clusters of epithelioid histiocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pattern of splenic involvement ?

A
  • pattern of involvement is variable
    • solitary or multiple fleshy nodules
    • diffuse white pulp involvement with colonization of the PALS
    • or diffuse red pulp involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a common variant of

PTLC, NOS ?

A
  • Lymphoepithelioid lymphoma
    • also known as Lenner Lymphoma
    • shows interfollicular growth
  • Cytology
    • predominantly small cells with slight nuclear irregularities
    • numerous and sometimes confluent epithelioid histiocytes
    • occasional, atypical proliferating blasts
    • admixed inflammatory cells with scattered R-S like cells that are usually EBV positive
  • IMP: HEV are not prominent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the immunophenotype

usually of the lymphoepithelioid variant ?

A
  • most cases are CD8+
  • cytotoxic profile

Note: this variant may have a somewhat better prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What should you watch out for

in general with T cell neoplasms and PTCL, NOS ?

A
  • sometimes they can only involve the paracortical region and surround reactive germinal centers
    • may mimic benign paracortical hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pattern of growth of

primary EBV-positive nodal T-cell

and NK-cell lymphomas ?

A
  • usually infiltrate in a monomorphic pattern
  • no angiodestruction and necrosis
    • unlike Extranodal NK-T cell lymphoma
  • for now they are considered a variant of PTCL, NOS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the immunophenotype

of PTCL, NOS ?

A
  • frequently down regulate CD5 and CD7
  • usually CD4 positive
    • but double positive, or negative as well as CD8 have been seen
  • CD56 positive
  • cytotoxic granules positive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What helps differentiate PTCL, NOS from

gamma-delta T cell lymphomas and extranodal

NK-T cell lymphomas ?

A
  • expression of T cell receptor beta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What immunophenotype can rarely

be expresed in PTCL, NOS?

A
  • CD15 and CD30 positivity

Note: these cases may show features overlapping with those of ALK-negative ALCL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Expression of what immunohistochemical

marker demonstrates a poor prognosis ?

A
  • CD15 expression shows a poor prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Expression of what two other markers may

have prognostic significance ?

A
  • TBX21 (also known as T-BET)
  • GATA3

These may be important for subclassification

17
Q

What other markers can be seen

in PTCL, NOS?

A
  • expression of a single TFH marker can be seen once in a while
  • CD52 (40%)
  • CD30 >25% expression in half the cases
    • cut off value for treatment is elusive
    • CD30+ does not seem to respond to treatment as well as ALCL
18
Q

Aberrant expression of what markers

can occasionally be seen ?

A
  • CD20 and CD79a
  • CD15
19
Q

What is the proliferation index usually ?

A
  • high, >70%
20
Q

What is the postulated normal counterpart

of PTCL, NOS ?

A
  • activated mature T cells
    • usually the CD4+ memory type of the adaptive immune system
21
Q

What is the genetic profile of PTCL, NOS?

A
  • TR genes are clonally rearranged in most
  • highly aberrant neoplasms with complex karyotypes with recurrent chromosomal gains and losses
  • aberrations differ from other T cell lymphomas like AITL and ALCL
  • gene expression profiling has identified subgroups
    • TBX21 (T-BET)
    • GATA3
  • no specific gene mutations have been attributed yet to PTCL,NOS
22
Q

What types of molecules are TBX21 and GATA3 ?

A
  • transcription factors that are master regulators of gene expression profiles in T helper cells
    • TBX21 may promote TH1 cells
    • GATA3 may promote TH2 cells
    • still has to be proven
23
Q

What is the differential diagnosis

of PTCL, NOS ?

A
  • ALK(-) ALCL
    • especially since CD30 is highly expressed in a subset of PTCL, NOS, but not strong and uniform as in ALCL
    • also ALCL will have more pronounced cytotoxic marker positivity and EMA
    • IMP:
      • ALCL carries genomic abberations in DUSP22 and TP53 that have not been shown in PTCL, NOS
24
Q

What are the prognostic and predictive

markers seen in PTCL, NOS ?

A
  • these are highly aggressive lymphomas with poor response to therapy
  • frequent relapses
  • IPI score only prognostic thing right now
25
Q

What morphologic findings have been

proposed as prognostic factors ?

A
  • involvement of the bone marrow
  • Ki67 proliferation index >70%

these are negative prognostic factors

26
Q

What findings are proposed as poor

prognosis in PTCL, NOS ?

A
  • EBV positivity
  • NF-KappaB pathway dysregulation
  • a high proliferation signature by gene expression
  • GATA3 expression
  • >70% transformed cells
  • cytotoxi profile
  • CD30 in most or all cells